First Header Logo Second Header Logo

Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: Pooled analysis from four phase 3 trials.

Feldman SR, Gomez B, Meng X, Germino R. Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: Pooled analysis from four phase 3 trials. J Dermatolog Treat. 2020 Jan 03; 1-7.

View in: PubMed